Document is current
Any future updates will be listed below
-
Authors
Ma, Zhen
Huebsch, Nathaniel
Koo, Sangmo
Mandegar, Mohammad A.
Siemons, Brian
Boggess, Steven
Conklin, Bruce R.
Grigoropoulos, Costas P.
Healy, Kevin E.
- License Information
-
More Information
Article History
Received: 11 September 2017
Accepted: 20 July 2018
First Online: 10 September 2018
Competing interests
: B.R.C. is a founder of Tenaya Therapeutics, a company focused on finding treatments for heart failure, including the use of CRISPR interference to interrogate genetic cardiomyopathies. B.R.C. holds equity in Tenaya Therapeutics, and Tenaya Therapeutics provides research support for heart failure-related research to B.R.C. K.E.H. and N.H. have a financial relationship with Organos, and both themselves and the company may benefit from commercialization of the results of this research. The other authors declare no competing interests.
